Menu ×

HEALTHCARE & PHARMACEUTICAL

Adrenergic Drug Market Segmentation By Drug Class (Vasopressors, Bronchodilators, Catecholamine and Others); By Route of Administration (Intravenous route, Oral Route and Inhalation); By Disease Indication (Bronchitis, Cardiac Arrest, Shock, Chronic Obstructive Pulmonary Disease and Others); By Distribution Channel (Retail Pharmacy, Hospital Pharmacy and Others) – Global Demand Analysis & Opportunity Outlook 2028

  • Text Size:

Extensive insights into the Growth of Adrenergic Drug Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More
IN THE NEWS

April 21, 2020: The first and only FDA approved, ready to use, Ephedrine injection (50 mg/10 ml vial) was announced by Nexus Pharmaceutical Incorporation by the trade name of Emerphed (ephedrine sulphate).

Introduction

Adrenergic drugs, which is also known as sympathomimetic drugs, are the type of medications which are used to simulate the sympathetic nervous system located in various parts of body such as lower back region of the spinal cord as well as chest. These drugs belong to a broad class of medications that bind to adrenergic receptors throughout the body. These receptors include beta1, beta2, beta3, alpha1 and alpha2. Adrenergic drugs directly bind to one or more of these receptors in order to induce various physiological effects, whereas, some drugs act indirectly at adrenergic receptors to induce certain effects. The main usage of these drugs is to increase the heartbeat, breathing rate, urine flow, sweating and prevent bleeding. These drugs have diverse applications in the treatment of various life-threatening conditions such as cardiac arrest, shock, asthma, chronic obstructive pulmonary diseases (COPD), allergic reactions and others. Adrenergic drugs stimulate the chemical messenger norepinephrine as well as epinephrine from the adrenal gland or replicate the chemical messenger actions.

Market Size and Forecast

The incidences of chronic obstructive pulmonary diseases (COPD), cardiac arrest and asthma is rising rapidly all across the world which is projected to drive the growth of adrenergic drug market in the upcoming future. According to the World Health Organisation, more than 251 million cases were reported globally for COPD in 2016. Additionally, new development of products, increase in the applications of these drugs for several disease indications and regulatory authority approval is predicted to boost up the market for adrenergic drug in the upcoming years. The global adrenergic drug market is anticipated to record a significant CAGR throughout the forecast period, i.e., 2020-2028. The market is segmented by drug class into vasopressors, bronchodilators, catecholamine and others, out of which, vasopressors segment is expected to grow at a significant rate owing to rising cardiac arrest cases worldwide.

Growth Drivers

Rising applications of adrenergic drug to grow the market in the upcoming years

The incidence of asthma, cardiac arrest and others are rising rapidly all over the world and so is the demand for adrenergic drug as they have multiple applications in the cure of several life-threatening conditions such as shock, cardiac arrest, COPD, allergic reactions and others. This factor is predicted to grow the market for adrenergic drug in the upcoming years.

Recent developments of the drug and its approval by regulatory authorities

Since adrenergic drugs are indicated in various life-threatening diseases, the company manufacturing these drugs are continuously working on its development so as to minimise its side effects and contraindication. Additionally, these drugs are approved for usage by the regulatory authorities. Thus, this factor is anticipated to play a significant role in expanding the adrenergic drug market size. CLICK TO DOWNLOAD SAMPLE REPORT

Restraints

Multiple side effects caused by the drug to hamper the growth

There are several side effects which are caused due to usage of adrenergic drugs such as arrythmia, hypertension, chest pain, hallucinations, nervousness and other severe health problems. The market is estimated to witness a limited growth in the upcoming years.

Basic contraindication associated with adrenergic agonist is predicted to limit the growth of the drug

There are certain conditions where the adrenergic drug is absolutely contraindicated such as hypersensitivity and conditions like glaucoma, hyperthyroidism, diabetes, hypokalemia, siezures and certain cardiac conditions, the use of adrenergic drugs can be harmful. So, this factor is anticipated to hamper the growth of adrenergic drugs market over the upcoming forecast period.

Market Segmentation

Our in-depth analysis of the adrenergic drug market includes the following segments:

By Drug Class

  • Vasopressors
  • Bronchodilators
  • Catecholamine
  • Others

By Route of Administration

  • Intravenous route
  • Oral route
  • Inhalation

By Disease Indication

  • Bronchitis
  • Cardiac Arrest
  • Shock
  • Chronic obstructive pulmonary disease
  • Others

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Others

By Region

On the basis of regional analysis, the global adrenergic drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America and Europe is anticipated to hold significantly large market share on the back of increasing concern for asthma, cardiac arrest and chronic obstructive pulmonary diseases in these regions and availability of favourable medical reimbursement policies and well-established healthcare facilities. On the other hand, the market in Asia Pacific is anticipated to gain significant growth on the back of rising number of people in India as well as China who are diagnosed with COPD as well as asthma, rapidly developing healthcare facilities and increasing expenditure in healthcare.

Introduction

Adrenergic drugs, which is also known as sympathomimetic drugs, are the type of medications which are used to simulate the sympathetic nervous system located in various parts of body such as lower back region of the spinal cord as well as chest. These drugs belong to a broad class of medications that bind to adrenergic receptors throughout the body. These receptors include beta1, beta2, beta3, alpha1 and alpha2. Adrenergic drugs directly bind to one or more of these receptors in order to induce various physiological effects, whereas, some drugs act indirectly at adrenergic receptors to induce certain effects. The main usage of these drugs is to increase the heartbeat, breathing rate, urine flow, sweating and prevent bleeding. These drugs have diverse applications in the treatment of various life-threatening conditions such as cardiac arrest, shock, asthma, chronic obstructive pulmonary diseases (COPD), allergic reactions and others. Adrenergic drugs stimulate the chemical messenger norepinephrine as well as epinephrine from the adrenal gland or replicate the chemical messenger actions.

Market Size and Forecast

The incidences of chronic obstructive pulmonary diseases (COPD), cardiac arrest and asthma is rising rapidly all across the world which is projected to drive the growth of adrenergic drug market in the upcoming future. According to the World Health Organisation, more than 251 million cases were reported globally for COPD in 2016. Additionally, new development of products, increase in the applications of these drugs for several disease indications and regulatory authority approval is predicted to boost up the market for adrenergic drug in the upcoming years. The global adrenergic drug market is anticipated to record a significant CAGR throughout the forecast period, i.e., 2020-2028. The market is segmented by drug class into vasopressors, bronchodilators, catecholamine and others, out of which, vasopressors segment is expected to grow at a significant rate owing to rising cardiac arrest cases worldwide.

Growth Drivers

Rising applications of adrenergic drug to grow the market in the upcoming years

The incidence of asthma, cardiac arrest and others are rising rapidly all over the world and so is the demand for adrenergic drug as they have multiple applications in the cure of several life-threatening conditions such as shock, cardiac arrest, COPD, allergic reactions and others. This factor is predicted to grow the market for adrenergic drug in the upcoming years.

Recent developments of the drug and its approval by regulatory authorities

Since adrenergic drugs are indicated in various life-threatening diseases, the company manufacturing these drugs are continuously working on its development so as to minimise its side effects and contraindication. Additionally, these drugs are approved for usage by the regulatory authorities. Thus, this factor is anticipated to play a significant role in expanding the adrenergic drug market size.

Restraints

Multiple side effects caused by the drug to hamper the growth

There are several side effects which are caused due to usage of adrenergic drugs such as arrythmia, hypertension, chest pain, hallucinations, nervousness and other severe health problems. The market is estimated to witness a limited growth in the upcoming years.

Basic contraindication associated with adrenergic agonist is predicted to limit the growth of the drug

There are certain conditions where the adrenergic drug is absolutely contraindicated such as hypersensitivity and conditions like glaucoma, hyperthyroidism, diabetes, hypokalemia, siezures and certain cardiac conditions, the use of adrenergic drugs can be harmful. So, this factor is anticipated to hamper the growth of adrenergic drugs market over the upcoming forecast period.

Market Segmentation

Our in-depth analysis of the adrenergic drug market includes the following segments:

By Drug Class

  • Vasopressors
  • Bronchodilators
  • Catecholamine
  • Others

By Route of Administration

  • Intravenous route
  • Oral route
  • Inhalation

By Disease Indication

  • Bronchitis
  • Cardiac Arrest
  • Shock
  • Chronic obstructive pulmonary disease
  • Others

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Others

By Region

On the basis of regional analysis, the global adrenergic drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America and Europe is anticipated to hold significantly large market share on the back of increasing concern for asthma, cardiac arrest and chronic obstructive pulmonary diseases in these regions and availability of favourable medical reimbursement policies and well-established healthcare facilities. On the other hand, the market in Asia Pacific is anticipated to gain significant growth on the back of rising number of people in India as well as China who are diagnosed with COPD as well as asthma, rapidly developing healthcare facilities and increasing expenditure in healthcare.

Adrenergic-Drug-Market

The adrenergic drug market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating the Market


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2020 Research Nester. All Rights Reserved